✦ LIBER ✦

3535 POSTER Phase II trial investigating the efficacy and safety of sunitinib in patients with unresectable hepatocellular carcinoma (HCC)

✍ Scribed by S.J. Faivre; E. Raymond; J. Douillard; E. Boucher; H.Y. Lim; J.S. Kim; S. Lanzalone; M.J. Lechuga; L. Sherman; A.L. Cheng

Book ID: 118625880
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 61 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71038-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6515 Continuous sunitinib treatment in p

6515 Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma (HCC): A multicenter phase II trial (SAKK 77/06 and SASL 23)

✍ Koeberle, D.; Montemurro, M.; Samaras, P.; Simcock, M.; Limacher, A.; Hess, V.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Safety and efficacy of sunitinib in pati

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

✍ Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB

470 Efficacy of nemorubicin (MMDX) admin

470 Efficacy of nemorubicin (MMDX) administered with iodinated oil via hepatic artery (IHA) to patients with unresectable primary hepatocellular carcinoma (HCC): phase II trial

✍ Y. Sun; J. Yang; P. Luo; Y. Zhang; Y. Yan; L. Sun; M.A. Pacciarini; O. Valota; C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 275 KB

1262 Safety of the phase III randomized

1262 Safety of the phase III randomized study of HYMITAQ vs. doxorubicin in unresectable hepatocellular carcinoma (HCC): ETHECC trial (Evaluation of thymitaq in HCC) vs. safety of the phase II program with THYMITAQ

✍ GISH, R 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

34 POSTER A phase II study of the combin

34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinoma

✍ M. Thomas; M. Lwasaki; K. Higginbotham; R. Lozano; K. Glover; J. Abbruzzese 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Efficacy and Safety of Regorafenib in Pa

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

✍ George, S.; Wang, Q.; Heinrich, M. C.; Corless, C. L.; Zhu, M.; Butrynski, J. E. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 248 KB